A leukemoid reaction is a dramatic spike in white blood cells, typically exceeding 50,000 cells per microliter, that looks alarming on a blood test but is not cancer. It’s the body’s extreme response to a serious infection, inflammation, or other physical stress. The name itself means “leukemia-like,” because the blood count can initially appear similar to what doctors see in blood cancers. The critical difference: a leukemoid reaction is temporary and resolves once the underlying trigger is treated.
Why the White Blood Cell Count Gets So High
A normal white blood cell count falls between roughly 4,500 and 11,000 cells per microliter. In a leukemoid reaction, that number can climb above 50,000 and occasionally reach 100,000. The cells driving this surge are almost always neutrophils, the frontline immune cells your body sends to fight bacterial invaders and control tissue damage.
When the body detects a serious threat, it sends chemical signals (including growth factors like G-CSF and GM-CSF) to the bone marrow, telling it to ramp up production and release white blood cells faster than usual. The marrow responds by pushing out not just fully mature neutrophils but also some younger, less developed forms. This flood of younger cells into the bloodstream is called a “left shift,” a term that comes from old lab diagrams where immature cells appeared on the left side of a chart. In a leukemoid reaction, the younger cells are mostly late-stage forms like band neutrophils, with only a small number of truly immature precursors. This pattern is one of the key features that separates it from leukemia.
Common Triggers
Severe bacterial infections are the most frequent cause. The body can mount a leukemoid-level response to pneumonia, sepsis, abscesses, tuberculosis, and Clostridium difficile colitis, among other infections. Any infection serious enough to produce a sustained, intense immune response can potentially push white blood cell counts into leukemoid territory.
Infections aren’t the only trigger. Solid tumors sometimes produce the same growth factors that stimulate the bone marrow, causing white cell counts to climb even without an active infection. This is called a paraneoplastic leukemoid reaction. Severe hemorrhage, acute hemolysis (rapid destruction of red blood cells), major burns, and intense physical stress can also provoke the response. Certain medications, particularly growth factor injections used to boost white blood cell production in cancer patients, and high-dose corticosteroids can push counts to leukemoid levels as well.
There’s also a lymphocytic version of the reaction, where lymphocytes rather than neutrophils dominate the spike. This pattern typically shows up in viral infections. Infectious mononucleosis, caused by Epstein-Barr virus, is a classic example. The virus infects one type of immune cell, triggering a massive expansion of another type (cytotoxic T cells) to fight it off. Similar lymphocyte surges can occur with HIV and cytomegalovirus infections.
How Doctors Tell It Apart From Leukemia
This is the central clinical question whenever someone presents with an extremely high white blood cell count. The distinction matters enormously because the treatment paths are completely different. Several features help doctors separate a leukemoid reaction from chronic myeloid leukemia (CML), the cancer it most closely resembles on paper.
Cell Maturity
In a leukemoid reaction, the vast majority of the elevated cells are mature or nearly mature neutrophils. CML, by contrast, shows significantly higher percentages of truly immature forms: myelocytes, promyelocytes, and blast cells. A blood smear in CML also tends to show elevated eosinophils and basophils, which are not a prominent feature of leukemoid reactions. In one comparative study, the optimal white blood cell cutoff of 45,000 cells per microliter identified 93% of CML cases, but overlap in total count alone makes cell type the more reliable distinguishing feature.
Toxic Changes Under the Microscope
Neutrophils in a leukemoid reaction often show visible signs of being battle-ready: heavy dark granules in the cell’s interior (toxic granulation), small bluish inclusions called Döhle bodies, and tiny vacuoles. These “toxic changes” reflect the intense immune activation driving the response. In CML, the white cells typically look clean and lack these features.
Enzyme Activity
A lab test measuring leukocyte alkaline phosphatase (LAP) activity in neutrophils provides another useful clue. LAP scores run normal or high in leukemoid reactions but are characteristically low in CML. This single test can quickly narrow the diagnosis, though it’s not definitive on its own.
Genetic Testing
The definitive answer comes from checking for the Philadelphia chromosome, a specific genetic abnormality found in CML cells. If it’s present, the diagnosis is CML. If it’s absent and the clinical picture fits, the diagnosis points toward a leukemoid reaction. This test can be done through cytogenetics, FISH analysis, or molecular testing for the BCR-ABL1 fusion gene.
What Happens After Diagnosis
A leukemoid reaction itself doesn’t require direct treatment. There’s no need to lower the white blood cell count artificially. The elevated count is a symptom, not the disease. Treatment focuses entirely on identifying and addressing whatever triggered the reaction in the first place.
If a bacterial infection is responsible, appropriate antibiotics typically bring the white count back down as the infection clears. If a medication is the cause, adjusting the dose or discontinuing it resolves the spike. For reactions driven by a solid tumor, treating the underlying cancer is the path forward. Once the trigger is controlled, the bone marrow stops its emergency production and white blood cell levels gradually return to normal.
What the Count Itself Can Tell You
While a leukemoid reaction is by definition not cancer, an extremely high white blood cell count still signals that something significant is going on in the body. The severity of the underlying condition often correlates with the degree of elevation. A white count of 60,000 driven by a severe infection tells doctors the body is under serious stress, even though the elevated count itself isn’t the primary danger.
The prognosis depends almost entirely on what’s causing the reaction. A leukemoid reaction from a treatable infection carries a very different outlook than one caused by an advanced solid tumor producing growth factors. In either case, the reaction resolves when the underlying condition does, making accurate diagnosis of the trigger the most important step in care.